Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01852877 · ClinicalTrials.gov registry record

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

A clinical trial of HIV Infections, sponsored by University of Illinois at Chicago.

Completed
Registry status
784
Enrollment target
3
Study locations

NCT01852877: Completed study of HIV Infections, sponsored by University of Illinois at Chicago.

NCT01852877 is a study of HIV Infections that has completed, run by University of Illinois at Chicago. The registered enrollment target is 784 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (77% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01852877, a study of HIV Infections, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
784 participants
Enrollment target
3
Study locations

Study Summary

Aim-1: Evaluate opt-out versus opt-in testing for the human immunodeficiency virus (HIV) at the Cook County jail and the Illinois Department of Corrections Northern Intake facilities. Outcomes of interest include a) uptake of each HIV testing strategy, b) comparative effectiveness of identifying HIV-positive cases, new cases and undisclosed cases, and c) predictors of HIV testing. Aim-2: Evaluate two case management strategies - "correctional case management" and "transitional case management" - designed to improve linkage and adherence to appropriate medical care after release from incarceration. Correctional case management is a longer-term, more intense approach while transitional case management seeks to meet the clients' immediate needs, link them to Ryan White case management, and then support the Ryan White case manager in assisting these clients. Correctional case management will be compared to the standard of care for jail detainees, and to transitional case management for persons leaving prison. Outcomes of interest include, (a) HIV viral load and CD4 cell counts over time, (b) adherence to medication, and (c) visits to medical providers. Aim-3: Evaluate the impact of an incentive for HIV-positive detainees released from jail to visit an HIV service organization where they can be linked to medical care and case management. Outcomes of interest are essentially the same as Aim-2. Aim-4: Assess university-based telemedicine as means to improve care of state prison inmates living with HIV. Outcomes of interest include medication regimens, HIV viral load and CD4 cell counts, and associated health conditions. Aim-5: Assess the uptake of partner notification and social network HIV counseling and testing involving HIV-positive persons released from jail and prison as a means to extend the reach of the 'seek, test, treat and retain' (STTR) model into the community.

Conditions Studied

Interventions

  • BEHAVIORAL Corrections case management

Study Locations (3)

Illinois

  • Illinois Department of Corrections - Chicago
  • University of Illinois at Chicago, School of Public Health, COIP - Chicago
  • Cermak Health Services, Cook County Jail - Chicago

Trial Details

FieldValue
Enrollment Target 784 participants
Start Date 2013-07
Est. Completion 2016-06-30
University of Illinois at Chicago

430 total trials

What the finished NCT01852877 record still lists

NCT01852877 is an observational study that tracks outcomes without assigning an intervention. The registered 784 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (77% higher).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Corrections case management is the first listed.

NCT01852877 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01852877 about?

NCT01852877 is a clinical study titled "Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois". Aim-1: Evaluate opt-out versus opt-in testing for the human immunodeficiency virus (HIV) at the Cook County jail and the Illinois Department of Corrections Northern Intake facilities. Outcomes of interest include a) uptake of each HIV testing strategy, b) comparative effectiveness of identifying HIV...

What is the current status of trial NCT01852877?

This trial is currently completed. The enrollment target is 784 participants. The study started on 2013-07. Estimated completion is 2016-06-30.

What conditions does trial NCT01852877 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT01852877?

The interventions under investigation include: Corrections case management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01852877?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01852877 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01852877's enrollment target sits among peer trials

784 40th of 542 higher than 503 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06118723 · 784 participants

    The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  • NCT06498128 · 785 participants

    Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

  • NCT06575192 · 783 participants · Phase 3

    Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants

  • NCT07276724 · 786 participants · Phase 3

    A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01852877, the US trial registry maintained by the National Library of Medicine. NCT01852877 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.